A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH
Phase 1
Recruiting
- Conditions
- Non-alcoholic Steatohepatitis
- Interventions
- Other: Placebo (B)Drug: INI-822 (A)
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Inipharm Australia Pty Ltd
- Target Recruit Count
- 104
- Registration Number
- NCT05945537
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
🇦🇺Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath